Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 15 (2), 137-139

Is It Safe to Prescribe Benzodiazepines or Opioids for Dyspnoea in Interstitial Lung Disease?

Affiliations

Is It Safe to Prescribe Benzodiazepines or Opioids for Dyspnoea in Interstitial Lung Disease?

Lydia J Finney. Breathe (Sheff).

Abstract

Low-dose opioids and benzodiazepines are not associated with increased risk of hospitalisation or death in patients with respiratory failure secondary to interstitial lung disease http://ow.ly/SCTl30o9bWq.

Conflict of interest statement

Conflict of interest: L.J. Finney has nothing to disclose.

Similar articles

See all similar articles

References

    1. Hutchinson J, McKeever T, Fogarty A. Increasing global mortality from idiopathic pulmonary fibrosis in the twenty-first century. Ann Am Thorac Soc; 11: 1176–1185. - PubMed
    1. Parshall MB, Schwartzstein RM, Adams L, et al. An Official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012; 185: 435–452. - PMC - PubMed
    1. Bajwah S, Higginson IJ, Ross JR, et al. Specialist palliative care is more than drugs: a retrospective study of ILD patients. Lung 2012; 190: 215–220. - PubMed
    1. Janssen DJ, de Hosson S, bij de Vaate E, et al. Attitudes toward opioids for refractory dyspnea in COPD among Dutch chest physicians. Chron Respir Dis 2015; 12: 85–92. - PubMed
    1. Bajwah S, Davies JM, Tanash H, et al. Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study. Eur Respir J 2018; 52: 1801278. - PubMed

LinkOut - more resources

Feedback